Lonza Group traded at 486.30 this Tuesday November 29th, decreasing 13.90 or 2.78 percent since the previous trading session. Looking back, over the last four weeks, Lonza Group lost 5.65 percent. Over the last 12 months, its price fell by 34.55 percent. Looking ahead, we forecast Lonza Group to be priced at 489.21 by the end of this quarter and at 449.53 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
486.30
Daily Change
-2.78%
Yearly
-34.55%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Covestro 38.29 1.26 3.40% -23.17%
Akzo Nobel 68.28 -0.38 -0.55% -26.52%
Alcon AG 64.16 -0.36 -0.56% -11.77%
Almirall SA 9.14 0.14 1.56% -14.94%
AstraZeneca 11,060.00 10.00 0.09% 33.64%
BASF 49.00 0.09 0.17% -15.35%
Bayer 56.04 0.29 0.52% 25.88%
Beiersdorf 102.95 -1.65 -1.58% 16.70%
DSM 119.95 -4.05 -3.27% -36.92%
Fresenius Medical Care 29.66 -0.13 -0.44% -43.80%
Fresenius 26.27 0.43 1.66% -21.57%
Geberit 445.60 -8.50 -1.87% -36.69%
Genmab 3,180.00 -53.00 -1.64% 25.30%
Givaudan 3,126.00 -119.00 -3.67% -30.53%
GN Store Nord 168.30 -2.40 -1.41% -55.36%
GlaxoSmithKline 1,417.80 23.00 1.65% -7.03%
Hikma Pharmaceutical 1,496.50 -9.00 -0.60% -32.44%
Johnson Matthey 2,137.00 9.00 0.42% 1.96%
Merck 172.10 -3.75 -2.13% -21.38%
Novartis 83.30 0.02 0.02% 13.43%
Philips 14.08 0.09 0.67% -54.86%
Roche Holding 309.25 -3.15 -1.01% -14.01%
Sanofi 88.19 0.30 0.34% 5.16%
Sika AG 232.80 -4.50 -1.90% -35.46%
Smith & Nephew PLC 1,078.00 -6.00 -0.55% -11.46%
Solvay 94.14 -2.22 -2.30% -4.83%
UCB 77.14 -0.52 -0.67% -19.76%
William Demant Holding 200.60 -7.80 -3.74% -36.05%

Indexes Price Day Year
CH20 11111 -84.35 -0.76% -8.62%

Lonza Group
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The Company divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.